U.S. Physical Therapy (NYSE:USPH) Issues Earnings Results

U.S. Physical Therapy (NYSE:USPH) posted its quarterly earnings data on Wednesday. The company reported $0.75 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06), Zacks reports. The firm had revenue of $214.06 million during the quarter, compared to analysts’ expectations of $211.36 million. U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The business’s quarterly revenue was up 8.5% on a year-over-year basis. During the same quarter last year, the business earned $0.81 earnings per share.

U.S. Physical Therapy Stock Down 3.1%

USPH traded down $2.43 during trading hours on Thursday, hitting $75.28. 288,864 shares of the company’s stock were exchanged, compared to its average volume of 215,608. The stock has a market cap of $1.15 billion, a price-to-earnings ratio of 150.79, a PEG ratio of 2.10 and a beta of 1.13. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.41. U.S. Physical Therapy has a 1-year low of $58.19 and a 1-year high of $93.50. The stock’s 50-day moving average is $69.62 and its two-hundred day moving average is $74.26.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 21st will be paid a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Friday, August 21st. U.S. Physical Therapy’s payout ratio is presently 368.00%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Peter Francis Minan bought 492 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The shares were acquired at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the acquisition, the director directly owned 2,923 shares in the company, valued at approximately $184,558.22. This represents a 20.24% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 2.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors and hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP boosted its holdings in shares of U.S. Physical Therapy by 3.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 491,726 shares of the company’s stock worth $38,403,000 after buying an additional 17,482 shares in the last quarter. Schroder Investment Management Group lifted its holdings in shares of U.S. Physical Therapy by 45.9% in the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock worth $29,603,000 after purchasing an additional 114,618 shares in the last quarter. Geode Capital Management LLC grew its position in U.S. Physical Therapy by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 355,237 shares of the company’s stock valued at $27,746,000 after purchasing an additional 1,097 shares during the period. Bank of America Corp DE grew its position in U.S. Physical Therapy by 77.2% in the 3rd quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock valued at $26,946,000 after purchasing an additional 138,194 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in U.S. Physical Therapy by 3.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 147,888 shares of the company’s stock worth $11,549,000 after buying an additional 5,207 shares during the last quarter.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on USPH shares. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, July 24th. Barrington Research dropped their price target on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Friday, May 29th. Citizens Jmp reissued a “market outperform” rating and set a $98.00 target price on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Finally, Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and a consensus price target of $97.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.